Breast Mri Background Parenchymal Enhancement As An Imaging Bridge To Molecular Cancer Sub-Type

ConclusionsBPE could play a crucial role as an imaging bridge to molecular breast cancer subtype allowing an additional risk stratification in the field of breast MRI and targeted screening tests. Luminal B (HER2-) tumors could prevail in case of mild BPE on CE-MRI examinations and TN tumors in patients with marked BPE. Further studies on larger series are needed to confirm this hypothesis.
Source: European Journal of Radiology - Category: Radiology Source Type: research